Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
ObjectiveMagnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is an effective treatment for essential tremor (ET) and tremor-dominant Parkinson's disease (PD), yet a substantial proportion of patients experience tremor recurrence over time. Reliable imaging biomarkers to predict long-term outcomes are lacking. The purpose of the study was to evaluate whether radiomic features extracted from 24-h post-treatment MRI can predict clinically relevant tremor recurrence at 12 months after MRgFUS thalamotomy, using a machine learning (ML) approach.Materials and methodsRetrospective, single-center study included 120 patients (61 ET, 59 PD) treated with unilateral MRgFUS Vim thalamotomy between February 2018 and June 2023. Tremor severity was assessed using part A of the Fahn-Tolosa-Marin Tremor Rating Scale (FTM-TRS) at baseline and 12 months. Recurrence was defined as an FTM-TRS part A score ≥ 3 at 12 months. Lesions were manually segmented on 24-h post-treatment T2-weighted MRI. Forty radiomic features (18 first-order, 22 texture GLCM from Laplacian of Gaussian-filtered images) were extracted. A linear Support Vector Classifier with leave-one-out cross-validation was used for classification. Model explainability was assessed using SHapley Additive exPlanations (SHAP).ResultsClinically relevant tremor recurrence occurred in 23 patients (19%). For the full cohort, the ML model achieved a balanced accuracy of 0.720, weighted F1-score of 0.737, and comparable sensitivity and specificity across classes. Performance was higher in PD (BA = 0.808, F1 = 0.793) than in ET (BA = 0.580, F1 = 0.696). The most predictive features were texture-derived GLCM metrics, particularly from edge-enhanced images, with first-order features contributing complementary information. No significant correlations were found between radiomic features and procedural parameters.ConclusionRadiomic analysis of MRgFUS lesions on 24-h post-treatment MRI can provide early prediction of 12-month tremor recurrence, with higher predictive value in PD than in ET. Texture-based features may capture microstructural characteristics linked to treatment durability. This approach could inform post-treatment monitoring and individualized management strategies.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.